Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma
Table 1
Studies regarding both AFP and PIVKA-II in the patients who underwent various treatment modalities for HCC.
Author
Year
Number of patients
Treatment modality
Tumor marker
Cutoff value of markers
Definition of tumor marker response (change from baseline)